Income Statement Gennex Laboratories Limited

Stocks

GENNEX6

INE509C01026

Pharmaceuticals

Market Closed - Bombay S.E. 06:02:27 2026-09-25 EDT			5-day change	1st Jan Change
10.10 ^INR	-0.49%		-1.66%	-29.37%

08-14	Gennex Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
05-30	Gennex Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

4a85d.ZGlz9AtkamnJ3qsmJKbEpj31JMVufVikbOWFJx7Dr-E.BS4wsUomA136uNNwTpCrlEjDQadZEhTpKJ3wQ1Lw3bURGwW-RhBeDoDn8g

Published financial data: GENNEX LABORATORIES LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Revenues	612M	656M	867M	1.38B	1.73B
Other Revenues, Total	-1	-	-	-1	-
Total Revenues	612M	656M	867M	1.38B	1.73B
Cost of Goods Sold, Total	384M	403M	494M	978M	1.29B
Gross Profit	228M	253M	374M	401M	437M
Selling General & Admin Expenses, Total	73.48M	80.63M	78.91M	88.01M	89.3M
Depreciation & Amortization - (IS)	7.88M	9.19M	23.68M	19.91M	26.48M
Other Operating Expenses	99.74M	123M	121M	142M	123M
Other Operating Expenses, Total	181M	213M	223M	250M	238M
Operating Income	46.88M	40.51M	150M	150M	199M
Interest Expense, Total	-8.77M	-13.54M	-30.76M	-36.08M	-41.98M
Interest And Investment Income	9M	26.61M	37.95M	95.71M	71.38M
Net Interest Expenses	228K	13.08M	7.19M	59.63M	29.4M
Currency Exchange Gains (Loss)	3.79M	4.15M	1.76M	2.39M	4.04M
Other Non Operating Income (Expenses)	-	5.5M	-	1.68M	0
EBT, Excl. Unusual Items	50.9M	63.23M	159M	214M	232M
Gain (Loss) On Sale Of Assets	34.52K	500K	5.79M	-206K	-
Insurance Settlements	-	-	-	-	-
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	50.94M	63.73M	165M	214M	232M
Income Tax Expense	11.7M	14.52M	33.17M	32.75M	22.59M
Earnings From Continuing Operations	39.23M	49.21M	132M	181M	210M
Net Income to Company	39.23M	49.21M	132M	181M	210M
Net Income - (IS)	39.23M	49.21M	132M	181M	210M
Net Income to Common Incl Extra Items	39.23M	49.21M	132M	181M	210M
Net Income to Common Excl. Extra Items	39.23M	49.21M	132M	181M	210M
Per Share Items
Net EPS - Basic	0.31	0.34	0.71	0.8	0.86
Basic EPS - Continuing Operations	0.31	0.34	0.71	0.8	0.86
Basic Weighted Average Shares Outstanding	127M	146M	187M	227M	243M
Net EPS - Diluted	0.31	0.34	0.61	0.78	0.86
Diluted EPS - Continuing Operations	0.31	0.34	0.61	0.78	0.86
Diluted Weighted Average Shares Outstanding	127M	146M	217M	231M	243M
Normalized Basic EPS	0.25	0.27	0.53	0.59	0.6
Normalized Diluted EPS	0.25	0.27	0.46	0.58	0.6
Supplemental Items
EBITDA	54.76M	49.7M	174M	170M	225M
EBITA	46.88M	40.51M	150M	150M	199M
EBIT	46.88M	40.51M	150M	150M	199M
EBITDAR	58.56M	51.61M	175M	173M	228M
Total Revenues (As Reported)	626M	696M	916M	1.48B	1.81B
Effective Tax Rate - (Ratio)	22.98	22.79	20.11	15.3	9.72
Total Current Taxes	13.2M	15.7M	34.1M	32.2M	20.5M
Total Deferred Taxes	-1.5M	-1.41M	-932K	547K	2.09M
Normalized Net Income	31.81M	39.52M	99.46M	134M	145M
Non-Cash Pension Expense	2.92M	1.77M	-398K	-378K	-43.59K
Supplemental Operating Expense Items
General and Administrative Expenses	-	-	-	1.5M	6M
Net Rental Expense, Total	3.8M	1.91M	966K	3.04M	2.91M
Imputed Operating Lease Interest Expense	3.05M	1.5M	1.31M	3.81M	2.63M
Imputed Operating Lease Depreciation	751K	403K	-344K	-770K	286K
Maintenance & Repair Expenses, Total	3.12M	3.79M	5.06M	7.34M	4.87M

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Assets
Cash And Equivalents	74.91M	142M	202M	75.89M	46.25M
Short Term Investments	-	-	400M	470M	7.93M
Total Cash And Short Term Investments	74.91M	142M	602M	546M	54.18M
Accounts Receivable, Total	113M	94.17M	178M	142M	436M
Other Receivables	8.06M	3.02M	12.13M	25.49M	24.88M
Notes Receivable	21.34M	-	34.2M	58.82M	67.02M
Total Receivables	143M	97.19M	224M	226M	527M
Inventory	77.37M	157M	252M	359M	539M
Prepaid Expenses	982K	2.43M	3.46M	2.59M	3.16M
Other Current Assets, Total	176M	88.15M	536M	677M	1.52B
Total Current Assets	472M	487M	1.62B	1.81B	2.65B
Gross Property Plant And Equipment	306M	852M	747M	834M	953M
Accumulated Depreciation	-169M	-176M	-197M	-215M	-242M
Net Property Plant And Equipment	137M	676M	550M	618M	711M
Long-term Investments	68.27M	100K	100K	100K	100K
Other Intangibles, Total	-	61.08M	29.41M	29.41M	29.41M
Deferred Tax Assets Long-Term	-	1.37M	2.31M	1.76M	-
Deferred Charges Long-Term	-	90.85M	90.85M	90.85M	90.85M
Other Long-Term Assets, Total	3.19M	6.47M	8.82M	8.7M	8.7M
Total Assets	680M	1.32B	2.3B	2.56B	3.49B
Liabilities
Accounts Payable, Total	77.41M	70.78M	152M	132M	203M
Accrued Expenses, Total	6.32M	6.11M	4.53M	5.9M	12.71M
Short-term Borrowings	101M	5.29M	24.62M	64.01M	66.7M
Current Portion of Long-Term Debt	-	5.25M	32.58M	38.18M	293M
Current Income Taxes Payable	20.81M	33.8M	52.6M	77.69M	84.62M
Other Current Liabilities	36.31M	174M	137M	128M	64.14M
Total Current Liabilities	242M	295M	403M	446M	724M
Long-Term Debt	-	163M	132M	169M	114M
Deferred Tax Liability Non Current	32.43K	-	-	-	330K
Other Non Current Liabilities	-	-	-	1	320M
Total Liabilities	242M	458M	535M	614M	1.16B
Common Stock, Total	127M	180M	227M	227M	243M
Additional Paid In Capital	60M	311M	1B	1B	1.22B
Retained Earnings	242M	303M	405M	568M	755M
Comprehensive Income and Other	9.25M	9.25M	68.79M	68.79M	11.59M
Total Common Equity	438M	803M	1.7B	1.87B	2.23B
Minority Interest	-	61.65M	60.83M	79M	103M
Total Equity	438M	865M	1.76B	1.95B	2.33B
Total Liabilities And Equity	680M	1.32B	2.3B	2.56B	3.49B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	127M	177M	227M	227M	243M
ECS Total Common Shares Outstanding	127M	177M	227M	227M	243M
Book Value / Share	3.46	4.55	7.49	8.21	9.16
Tangible Book Value	438M	742M	1.67B	1.84B	2.2B
Tangible Book Value Per Share	3.46	4.2	7.36	8.08	9.04
Total Debt	101M	173M	189M	271M	474M
Net Debt	26.33M	31.28M	-413M	-275M	420M
Debt Equivalent Oper. Leases	30.37M	15.26M	7.72M	24.28M	23.3M
Minority Interest, Total (Incl. Fin. Div)	-	61.65M	60.83M	79M	103M
Equity Method Investments, Total	68.17M	-	-	-	-
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	20.11M	26.78M	32.61M	102M	174M
Inventories - Work In Process, Total	42.83M	52.39M	103M	135M	170M
Inventories - Finished Goods, Total	11.48M	71.89M	111M	115M	191M
Inventories - Others	2.95M	5.86M	4.58M	8.14M	4.67M
Land - (BS)	84.18M	115M	110M	118M	121M
Buildings, Total	20.26M	165M	120M	135M	145M
Machinery, Total	202M	483M	405M	443M	463M
Full Time Employees	115	118	129	115	125

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Net Income	39.23M	49.21M	132M	181M	210M
Depreciation & Amortization - CF	7.88M	9.19M	23.68M	19.91M	26.48M
Depreciation & Amortization, Total	7.88M	9.19M	23.68M	19.91M	26.48M
(Gain) Loss From Sale Of Asset	-	-	-	-	-
Other Operating Activities, Total	20.2M	1.45M	25.98M	-59.06M	-28.88M
Change In Accounts Receivable	-23.67M	18.97M	-83.95M	36.5M	-294M
Change In Inventories	-27.18M	-79.56M	-94.82M	-108M	-179M
Change In Accounts Payable	22.13M	124M	20.5M	-20.21M	7.36M
Change in Other Net Operating Assets	27.77M	113M	-490M	-159M	-378M
Cash from Operations	66.36M	237M	-467M	-108M	-637M
Capital Expenditure	-3.9M	-398M	-	-89.47M	-119M
Sale of Property, Plant, and Equipment	287K	500K	154M	2M	-
Investment in Marketable and Equity Securities, Total	-	-12.54M	-	-	-
Other Investing Activities, Total	-9M	26.61M	35.6M	95.71M	71.38M
Cash from Investing	-12.61M	-383M	189M	8.24M	-47.99M
Short Term Debt Issued, Total	27.62M	-	-	44.98M	265M
Long-Term Debt Issued, Total	-	10.18M	-	36.77M	257M
Total Debt Issued	27.62M	10.18M	-	81.75M	523M
Short Term Debt Repaid, Total	-	-90.7M	-	-	-
Long-Term Debt Repaid, Total	-155K	-	-30.72M	-	-
Total Debt Repaid	-155K	-90.7M	-30.72M	-	-
Issuance of Common Stock	-	304M	798M	-	172M
Other Financing Activities, Total	-8.77M	-13.54M	-30.76M	-36.08M	-41.98M
Cash from Financing	18.69M	210M	737M	45.67M	653M
Miscellaneous Cash Flow Adjustments	-	-	-	1K	-
Net Change in Cash	72.44M	63.81M	459M	-54.06M	-31.51M
Supplemental Items
Cash Interest Paid	8.77M	13.54M	30.76M	36.08M	41.98M
Cash Income Tax Paid (Refund)	11.1M	-	-	32.2M	22.59M
Levered Free Cash Flow	29.87M	-176M	-512M	-250M	-1.3B
Unlevered Free Cash Flow	35.35M	-167M	-492M	-228M	-1.27B
Change In Net Working Capital	-2.06M	-196M	610M	252M	1.31B
Net Debt Issued / Repaid	27.46M	-80.52M	-30.72M	81.75M	523M

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Profitability
Return on Assets	4.62	2.53	5.18	3.87	4.11
Return on Total Capital	5.8	3.21	6.27	4.51	4.95
Return On Equity %	9.39	7.55	10.02	9.77	9.82
Return on Common Equity	9.39	7.93	10.51	10.15	10.25
Margin Analysis
Gross Profit Margin %	37.24	38.58	43.08	29.07	25.31
SG&A Margin	12	12.29	9.1	6.38	5.17
EBITDA Margin %	8.95	7.58	20.05	12.36	13.05
EBITA Margin %	7.66	6.17	17.32	10.91	11.52
EBIT Margin %	7.66	6.17	17.32	10.91	11.52
Income From Continuing Operations Margin %	6.41	7.5	15.19	13.14	12.14
Net Income Margin %	6.41	7.5	15.19	13.14	12.14
Net Avail. For Common Margin %	6.41	7.5	15.19	13.14	12.14
Normalized Net Income Margin	5.2	6.02	11.47	9.71	8.41
Levered Free Cash Flow Margin	4.88	-26.8	-58.99	-18.14	-75.3
Unlevered Free Cash Flow Margin	5.77	-25.51	-56.78	-16.5	-73.78
Asset Turnover
Asset Turnover	0.96	0.65	0.48	0.57	0.57
Fixed Assets Turnover	4.4	1.61	1.41	2.36	2.6
Receivables Turnover (Average Receivables)	6.04	6.33	6.37	8.63	5.99
Inventory Turnover (Average Inventory)	6.02	3.44	2.42	3.2	2.87
Short Term Liquidity
Current Ratio	1.95	1.65	4.01	4.07	3.66
Quick Ratio	0.81	0.81	1.97	1.6	0.71
Operating Cash Flow to Current Liabilities	0.27	0.8	-1.16	-0.24	-0.88
Days Sales Outstanding (Average Receivables)	60.4	57.67	57.46	42.31	60.98
Days Outstanding Inventory (Average Inventory)	60.6	106.12	151.52	114.02	127.07
Average Days Payable Outstanding	60.72	56.05	69.22	47.63	41.55
Cash Conversion Cycle (Average Days)	60.28	107.74	139.76	108.7	146.5
Long Term Solvency
Total Debt/Equity	23.11	20.04	10.73	13.93	20.34
Total Debt / Total Capital	18.77	16.7	9.69	12.23	16.9
LT Debt/Equity	-	18.83	7.49	8.68	4.9
Long-Term Debt / Total Capital	-	15.68	6.76	7.62	4.07
Total Liabilities / Total Assets	35.59	34.61	23.27	24	33.22
EBIT / Interest Expense	5.34	2.99	4.88	4.17	4.74
EBITDA / Interest Expense	6.24	3.67	5.65	4.72	5.37
(EBITDA - Capex) / Interest Expense	5.8	-25.72	5.65	2.24	2.53
Total Debt / EBITDA	1.85	3.49	1.09	1.59	2.1
Net Debt / EBITDA	0.48	0.63	-2.38	-1.61	1.86
Total Debt / (EBITDA - Capex)	1.99	-0.5	1.09	3.35	4.47
Net Debt / (EBITDA - Capex)	0.52	-0.09	-2.38	-3.4	3.96
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	2.62	7.17	32.18	59.03	25.26
Gross Profit, 1 Yr. Growth %	-3.88	11.02	47.59	7.3	9.09
EBITDA, 1 Yr. Growth %	-17.78	-9.24	249.81	-2	42.52
EBITA, 1 Yr. Growth %	-18.89	-13.59	270.75	0.19	32.21
EBIT, 1 Yr. Growth %	-18.89	-13.59	270.75	0.19	32.21
Earnings From Cont. Operations, 1 Yr. Growth %	-2.85	25.43	167.74	37.55	15.76
Net Income, 1 Yr. Growth %	-2.85	25.43	167.74	37.55	15.76
Normalized Net Income, 1 Yr. Growth %	-6.32	24.22	151.67	34.59	8.5
Diluted EPS Before Extra, 1 Yr. Growth %	-2.78	8.62	90.6	28.78	10.28
Accounts Receivable, 1 Yr. Growth %	26.46	-16.77	89.15	-20.49	207.58
Inventory, 1 Yr. Growth %	54.16	102.83	60.43	42.76	49.94
Net Property, Plant and Equip., 1 Yr. Growth %	-3.03	393.83	-18.66	12.36	15.02
Total Assets, 1 Yr. Growth %	15.49	94.51	73.82	11.33	36.18
Tangible Book Value, 1 Yr. Growth %	10.34	69.44	125.54	9.74	19.5
Common Equity, 1 Yr. Growth %	10.34	83.38	112.05	9.57	19.19
Cash From Operations, 1 Yr. Growth %	-561.77	98.82	-297.19	-76.87	565.88
Capital Expenditures, 1 Yr. Growth %	394.66	2.4K	-	-	100.34
Levered Free Cash Flow, 1 Yr. Growth %	-199.56	-1.09K	190.92	-51.11	459.58
Unlevered Free Cash Flow, 1 Yr. Growth %	-239.45	-818.23	194.14	-53.78	507.19
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	4.34	4.87	19.02	44.99	41.14
Gross Profit, 2 Yr. CAGR %	1.19	3.3	28.01	25.85	8.19
EBITDA, 2 Yr. CAGR %	18.31	-13.61	78.18	85.15	13.87
EBITA, 2 Yr. CAGR %	26.98	-16.28	78.99	92.74	15.09
EBIT, 2 Yr. CAGR %	26.98	-16.28	78.99	92.74	15.09
Earnings From Cont. Operations, 2 Yr. CAGR %	45.38	10.39	83.25	91.91	26.19
Net Income, 2 Yr. CAGR %	45.38	10.39	83.25	91.91	26.19
Normalized Net Income, 2 Yr. CAGR %	44.53	7.88	76.81	84.05	20.84
Diluted EPS Before Extra, 2 Yr. CAGR %	45.38	2.76	40.02	56.67	19.17
Accounts Receivable, 2 Yr. CAGR %	34.22	2.59	25.47	22.63	56.38
Inventory, 2 Yr. CAGR %	1.99	76.83	80.39	51.34	46.31
Net Property, Plant and Equip., 2 Yr. CAGR %	-4.21	118.83	100.42	-4.4	13.68
Total Assets, 2 Yr. CAGR %	9.3	49.88	83.87	39.11	23.13
Tangible Book Value, 2 Yr. CAGR %	10.83	36.73	95.49	57.32	14.52
Common Equity, 2 Yr. CAGR %	10.83	42.25	97.2	52.43	14.28
Cash From Operations, 2 Yr. CAGR %	99.27	305.89	98	-32.47	16.77
Capital Expenditures, 2 Yr. CAGR %	15.02	2.15K	-	-52.58	-
Levered Free Cash Flow, 2 Yr. CAGR %	101.28	142.11	435.78	19.26	59.45
Unlevered Free Cash Flow, 2 Yr. CAGR %	264.42	156.96	359.63	16.6	60.89
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	2.81	5.27	13.28	31.09	38.09
Gross Profit, 3 Yr. CAGR %	-0.44	4.36	16.35	20.7	19.99
EBITDA, 3 Yr. CAGR %	4.91	8.3	37.69	45.99	65.53
EBITA, 3 Yr. CAGR %	7.64	11.69	37.48	47.51	69.98
EBIT, 3 Yr. CAGR %	7.64	11.69	37.48	47.51	69.98
Earnings From Cont. Operations, 3 Yr. CAGR %	20.89	38.4	48.32	66.54	62.15
Net Income, 3 Yr. CAGR %	20.89	38.4	48.32	66.54	62.15
Normalized Net Income, 3 Yr. CAGR %	18.91	37.42	43.07	61.44	54.32
Diluted EPS Before Extra, 3 Yr. CAGR %	20.89	31.92	23.99	36.17	39.37
Accounts Receivable, 3 Yr. CAGR %	2.85	14.46	25.8	7.77	66.62
Inventory, 3 Yr. CAGR %	13.25	28.26	71.18	66.86	50.87
Net Property, Plant and Equip., 3 Yr. CAGR %	-4.32	65.48	57.34	65.26	1.68
Total Assets, 3 Yr. CAGR %	9.56	32.45	57.47	55.55	38.12
Tangible Book Value, 3 Yr. CAGR %	9.02	27.68	61.56	61.26	43.54
Common Equity, 3 Yr. CAGR %	9.02	31.09	62.5	62.12	40.43
Cash From Operations, 3 Yr. CAGR %	52.38	141.97	219.08	-3.21	39.05
Capital Expenditures, 3 Yr. CAGR %	-27.94	413.09	-	77.71	-33.05
Levered Free Cash Flow, 3 Yr. CAGR %	9.87	187.86	157.4	141.21	94.84
Unlevered Free Cash Flow, 3 Yr. CAGR %	26.28	297.66	168.8	113.74	96.73
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	7.87	8.15	9.01	19.65	23.7
Gross Profit, 5 Yr. CAGR %	5.16	7.88	10.09	12.48	13.01
EBITDA, 5 Yr. CAGR %	3.29	10.29	29.66	34.21	27.61
EBITA, 5 Yr. CAGR %	4.18	13.79	31.92	38.93	28.05
EBIT, 5 Yr. CAGR %	4.18	13.79	31.92	38.93	28.05
Earnings From Cont. Operations, 5 Yr. CAGR %	7.73	42.56	42.77	57.73	39.03
Net Income, 5 Yr. CAGR %	7.73	42.56	42.77	57.73	39.03
Normalized Net Income, 5 Yr. CAGR %	10.43	35.17	39.36	54.45	33.73
Diluted EPS Before Extra, 5 Yr. CAGR %	7.73	38.54	28.2	39.78	22.04
Accounts Receivable, 5 Yr. CAGR %	1.9	-2.08	11.37	17.66	37.24
Inventory, 5 Yr. CAGR %	21.76	46.33	36.43	37.04	60.76
Net Property, Plant and Equip., 5 Yr. CAGR %	-2.74	34.13	28.61	32.87	38.16
Total Assets, 5 Yr. CAGR %	6.69	21.26	34.77	35.07	42.71
Tangible Book Value, 5 Yr. CAGR %	7.21	18.5	37.7	38.8	40.78
Common Equity, 5 Yr. CAGR %	7.21	20.39	38.19	39.24	41.15
Cash From Operations, 5 Yr. CAGR %	127.58	49.61	90.2	45.23	113.44
Capital Expenditures, 5 Yr. CAGR %	-17.2	120.57	-	97.93	172.96
Levered Free Cash Flow, 5 Yr. CAGR %	1.7	59.52	86.76	102.35	112.53
Unlevered Free Cash Flow, 5 Yr. CAGR %	7.2	50.62	94.79	143.43	118.91